IRIS Tipologia:https://hdl.handle.net/10807/2112026-08-02T17:44:00Z2026-08-02T17:44:00ZDeontological Ethicshttps://hdl.handle.net/10807/3439562026-07-31T00:38:23Z2026-01-01T00:00:00ZTitolo: Deontological Ethics
Autori: Gaj, N.
Abstract: Deontology is a normative theory that conceives moral duties as constraints on what agents may or may not do. The chapter begins by examining central features of deontological ethics, emphasizing both the strengths and the limitations of traditional formulations. This sets the stage for introducing moderate deontology, which holds that duties are strictly binding only when abstracted from concrete circumstances. These considerations are crucial for situating psychological practices, understood as nested action plans that, as they unfold, generate new opportunities for and constraints on action. Attending to real-life circumstances in ethical deliberation inevitably draws attention to an axiological dimension alongside the normative, prompting the claim that deontological and teleological considerations require an integrated treatment. The final section analyzes selected elements of the Ethical Principles of Psychologists and Code of Conduct (American Psychological Association, 2017) against the backdrop of the preceding theoretical discussion.2026-01-01T00:00:00ZSubjective cognitive declinehttps://hdl.handle.net/10807/3410892026-06-27T00:18:26Z2025-01-01T00:00:00ZTitolo: Subjective cognitive decline
Autori: Marina Maffoni; Annalisa Magnani
Abstract: This entry provides a comprehensive overview of Subjective Cognitive Decline (SCD), emphasizing its significance as an early marker in the continuum of physiological cognitive aging and neurodegenerative diseases—such as Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD). The discussion begins with a brief introduction to the phenomenon of population aging and the various forms of neurocognitive disorders. Subsequently, Subjective Cognitive Decline (SCD) is introduced, with an outline of its definition, prevalence, and role in the progression of cognitive disorders. The complex nature of SCD is further explored through its diagnostic challenges, emphasizing the integration of subjective assessments with advanced biomarkers to enhance accuracy and early detection. The paper progresses by examining the evolution and clinical trajectories of SCD, which range from symptom remission to potential progression to MCI or AD. Key risk and protective factors are discussed, highlighting the importance of cognitive reserve, lifestyle interventions, and psychosocial support in mitigating the risk of progression. Attention is also given to the
ethical considerations of early diagnosis, particularly the potential psychological and social consequences of false positives and the need for transparent patient-clinician communication. In terms of management, the entry delves into non-pharmacological interventions (NPIs), exploring tailored strategies such as cognitive training, mindfulness-based therapies, and technology-driven solutions, including virtual reality (VR) and telemedicine. These approaches are compared with traditional rehabilitation methods to assess their efficacy and accessibility. Finally, the entry concludes by identifying critical areas for future research, including the refinement of diagnostic tools, validation of predictive biomarkers, and the standardization of assessment protocols. The overarching aim is to develop a unified framework for the understanding and management of SCD that aligns with the diverse needs of an aging population.2025-01-01T00:00:00ZGioachimismohttps://hdl.handle.net/10807/3410412026-06-27T00:19:03Z2025-01-01T00:00:00ZTitolo: Gioachimismo
Autori: rainini, marco2025-01-01T00:00:00ZGioacchino da Fiorehttps://hdl.handle.net/10807/3410402026-06-27T00:18:57Z2025-01-01T00:00:00ZTitolo: Gioacchino da Fiore
Autori: rainini, marco2025-01-01T00:00:00Z